Identifying the common pathologies and molecular mechanisms involved in retinal and brain neurodegeneration could open up new opportunities in preventing type 2 diabetes-related cognitive impairment.

The pre-enrollment period for the 2022-2023 academic year of the Master in Translational Biomedical Research at VHIR will be open from January 10 to September 5, 2022, or until all places are filled.

The Scoliosis Research Society (SRS) has awarded with this prestigious recognition Dr. Pellisé's team for the study on the similarity of the adverse effects of surgeries both in elderly patients and in the general adult population.

The project COCREA SASI. Co creation for the promotion of affective-sexual health from an intercultural perspective has won the award for Best Research Paper.

The study shows the therapeutic effect of a new drug called 4SC-205 in new mouse neuroblastoma models, where it is effective in reducing the growth of the tumour.

This year, the Vall d'Hebron team has participated in the publication of three articles to understand the 2016 enterovirus A71 (EV-A71) outbreak in Catalonia and the follow-up of non-polio enteroviruses today.

The solidarity activities of the foundation allow them to raise more money every year for the research of this disease.

L'estudi ECMOVIBER, realitzat a partir de 338 pacients que han rebut suport amb ECMO per una infecció per coronavirus greu a 24 centres d'Espanya i Portugal, detecta els factors associats amb una major mortalitat hospitalària.

Des del 27 de desembre fins al 9 de gener de 2022 es podrà visitar a la sala Àgora del CosmoCaixa.

With this grant the project Synthetic cells to improve the control of viral infections will receive support to accelerate its arrival to society.

Vall d’Hebron and UAB researchers studied the antitumoral action of protein kinase ERK5 inhibitor drugs, and found out they accelerate toxic autophagy.

Dels 117 pacients trasplantats d’òrgan sòlid infectats per SARS-CoV-2 en els vuit mesos que comprèn l’estudi (de novembre a juny de 2021), un 88% van infectar-se en el període prevacunació (103 pacients, que van contreure COVID-19 de novembre a març).

És el primer cop que s’analitzen totes les cèl·lules que conformen el reservori del VIH a la sang a la vegada, descrivint de quina manera i en quins subtipus de cèl·lules en concret s’ubica aquest reservori en persones que reben tractament antiretroviral

El Dr. Josep Antoni Ramos Quiroga, la Dra. Núria Gómez Barros, la Dra. Sala Guila, el Dr. Francisco Collazos i el Dr. Marc Ferrer, del Servei de Salut Mental de Vall d’Hebron, han aparegut al llarg de les més de 15 hores de programa.

A multicenter study, led by neurologists at the Research Instituto of the Sant Pau Hospital and with the participation of the main Catalan hospitals, analyses the relationship between stroke and COVID.

The United Nations General Assembly adopted last December 16th the Resolution on "Addressing the Challenges of Persons Living with a Rare Disease and their Families”.

In this IV edition, 4,800 euros have been raised, which will go to the Biomedical Research in Gynecology group at Vall d'Hebron Research.

This work is the base to develop an integrate research platform focus on this pathology.

La 25a Conferència Anual ha anat a càrrec del Dr. Àlvaro Pascual-Leone, professor de Neurologia a Harvard Medical School i director del Guttmann Brain Health Institute.

L’espai que ocuparan els laboratoris de recerca es duplica, arribant als 5.569 m2.

FunHoMic integrates experts in fungal pathogenesis, immunology, microbial ecology and "omics" technologies to train 13 researchers to identify biomarkers related to the risk of infection by fungi such as Candida.

This new method, developed by the Nephrology and Renal Transplantation group of VHIR, will facilitate the collection of urine and feces samples from animals in biomedical research.

The study, led by Anna Beneria, specialist physician of the Mental Health Service, concludes that these methodologies have shortcomings and proposes the implementation of improvements in the follow-up of young people.

La comissió EASL-Lancet, en què ha participat la Dra. María Buti, ha analitzat possibles millores per a la prevenció i la detecció precoç d'aquestes patologies.